CXCL9 and CXCL10 accelerate acute transplant rejection mediated by alloreactive memory t cells in a mouse retransplantation model

Experimental and Therapeutic Medicine

Volumn 8, Issue 1, 2014, Pages 237-242

  Zhuang, Jia Wei ^a   Shan, Zhong Gui ^a   Ma, Teng ^a   Li, Chun ^b   Qiu, Shui Wei ^a   Zhou, Xiao Biao ^a   Lin, Lian Feng ^a   Qi, Zhong Quan ^b  

^a THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^b XIAMEN UNIVERSITY   (China)

Author keywords

C X C motif chemokine ligand 10; C X C motif chemokine ligand 9; Heart transplantation; Memory T cells; Retransplantation

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 2; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CLINICAL EVALUATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; HISTOLOGY; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; RETRANSPLANTATION; RNA ISOLATION; SKIN TRANSPLANTATION;

EID: 84901331435     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1714     Document Type: Article

References (26)

1. Luo L, Li C, Wu W, Lu J, et al: Functional analysis of alloreactive memory CD4+ T cells derived from skin transplantation recipient and naïve CD4+ T cells derived from untreated mice. J Surg Res 176: 649-656, 2012.
2. McFarland RD, Douek DC, Koup RA and Picker LJ: Identification of a human recent thymic emigrant phenotype. Proc Natl Acad Sci USA 97: 4215-4220, 2000.
3. Douek DC, McFarland RD, Keiser PH, et al: Changes in thymic function with age and during the treatment of HIV infection. Nature 396: 690-695, 1998.
4. Van Arendonk KJ, Garonzik Wang JM, Deshpande NA, James NT, Smith JM, Montgomery RA, Colombani PM and Segev DL: Practice patterns and outcomes in retransplantation among pediatric kidney transplant recipients. Transplantation 95: 1360-1368, 2013.
5. Johnson MR, Aaronson KD, Canter CE, Kirklin JK, Mancini DM, Mehra MR, Radovancevic B, Taylor DO and Webber SA: Heart retransplantation. Am J Transplant 7: 2075-2081, 2007.
6. Saito A, Novick RJ, Kiaii B, McKenzie FN, Quantz M, Pflugfelder P, Fisher G and Chu MW: Early and late outcomes after cardiac retransplantation. Can J Surg 56: 21-26, 2013.
7. Richters CD, Hoekstra MJ, et al: Immunology of skin transplantation. Clin Dermatol 23: 338-342, 2005.
8. Game DS and Lechler RI: Pathways of allorecognition: implications for transplantation tolerance. Transpl Immunol 10: 101-108, 2002.
9. Sánchez Lázaro IJ, Almenar Bonet L, Moro López J, Sánchez Lacuesta E, Martínez-Dolz L, Agüero Ramón-Llín J, et al: Influence of traditional cardiovascular risk factors in the recipient on the development of cardiac allograft vasculopathy after heart transplantation. Transplant Proc 40: 3056-3057, 2008.
10. Springer TA: Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 57: 827-872, 1995.
11. Flach R, Speidel N, Flohé S, Börgermann J, Dresen IG, Erhard J and Schade FU: Analysis of intragraft cytokine expression during early reperfusion after liver transplantation using semi-quantitative RT-PCR. Cytokine 10: 445-451, 1998.
12. Rosenblum JM, Shimoda N, Schenk AD, Zhang H, Kish DD, Keslar K, Farber JM and Fairchild RL: CXC chemokine ligand (CXCL) 9 and CXCL10 are antagonistic costimulation molecules during the priming of alloreactive T cell effectors. J Immunol 184: 3450-3460, 2010.
13. Matsuura A, Abe T and Yasuura K: Simplified mouse cervical heart transplantation using a cuff technique. Transplantation 51: 896-898, 1991.
14. Billingham ME, Cary NR, Hammond ME, Kemnitz J, Marboe C, McCallister HA, et al: A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant 9: 587-593, 1990.
15. Winters GL, Marboe CC and Billingham ME: The International Society for Heart and Lung Transplantation grading system for heart transplant biopsy specimens: clarification and commentary. J Heart Lung Transplant 17: 754-760, 1998.
16. Koga S, Auerbach MB, Engeman TM, Novick AC, Toma H and Fairchild RL: T cell infiltration into class II MHC-disparate allografts and acute rejection is dependent on the IFN-gamma-induced chemokine Mig. J Immunol 163: 4878-4885, 1999.
17. Watarai Y, Koga S, Paolone DR, Engeman TM, Tannenbaum C, Hamilton TA and Fairchild RL: Intraallograft chemokine RNA and protein during rejection of MHC-matched/multiple minor histocompatibility-disparate skin grafts. J Immunol 164: 6027-6033, 2000.
18. Miura M, Morita K, Kobayashi H, Hamilton TA, Burdick MD, Strieter RM and Fairchild RL: Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection. J Immunol 167: 3494-3504, 2001.
19. Hancock WW, Gao W, Csizmadia V, Faia KL, Shemmeri N and Luster AD: Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 193: 975-980, 2001.
20. Liang H, Zhao Y, San Z, Liao C, Sha C, Xie B, Chen J, Xia J, Wang Y and Qi Z: The recall alloresponse following retransplantation is more intense compared with the T cell memory-transfer model. Immunol Invest 39: 39-53, 2010.
21. Zhou X, Shan Z, Liang H, et al: Role of regulated upon activation normal T-cell expressed and secreted in a model of retransplantation acute rejection mediated by alloreactive memory CD4+ T cells. Transplant Proc 45: 546-551, 2013.
22. Roedder S, Vitalone M, Khatri P and Sarwal MM: Biomarkers in solid organ transplantation: establishing personalized transplantation medicine. Genome Med 3: 37, 2011.
23. Romagnani P and Crescioli C: CXCL10: a candidate biomarker in transplantation. Clin Chim Acta 413: 1364-1373, 2012.
24. Liang H, Liao C, Qi Z, et al: Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice. Transpl Immunol 22: 128-136, 2010.
25. Agostini C, Calabrese F, Rea F, et al: Cxcr3 and its ligand CXCL10 are expressed by inflammatory cells infiltrating lung allografts and mediate chemotaxis of T cells at sites of rejection. Am J Pathol 158: 1703-1711, 2001.
26. Belperio JA, Keane MP, Burdick MD, et al: Role of CXCL9/CXCR3 chemokine biology during pathogenesis of acute lung allograft rejection. J Immunol 171: 4844-4852, 2003.